Results 201 to 210 of about 44,530 (269)

Apolipoprotein A‐I (CSL112) and Cardiovascular Outcomes in Atherosclerotic Cardiovascular Disease: A Scoping Review

Clinical Cardiology, Volume 49, Issue 5, May 2026.
Apolipoprotein A‐I (ApoA‐I), the principal protein of HDL, plays a key role in reverse cholesterol transport, inflammation modulation, and plaque stabilization in atherosclerotic cardiovascular disease. Emerging ApoA‐I–based therapies, including CSL112, enhance cholesterol efflux capacity, though definitive reductions in cardiovascular events remain ...
Awais Habib, Muhammad Saood Moazzam Khan, Ahmad Aneeq, Hafiz Muhammad Talha Tahir, Amin Mehmoodi, Jahanzeb Malik, Abida Perveen   +6 more
wiley   +1 more source

The Association of the Cholesterol Efflux Capacity with the Paraoxonase 1 Q192R Genotype and the Paraoxonase Activity. [PDF]

J Atheroscler Thromb
Oniki K, Ohura K, Endo M, Akatwijuka D, Matsumoto E, Nakamura T, Ogata Y, Yoshida M, Harada-Shiba M, Saruwatari J, Ogura M, Imai T.   +11 more
europepmc   +1 more source

Cholesterol efflux capacity of high-density lipoprotein was not associated with cognitive decline and brain structures in older people with diabetes mellitus. [PDF]

J Diabetes Investig, 2022
Wu Y, Tan KC, Shiu SW, Luo Y, Shi L, Kwok TC.   +5 more
europepmc   +1 more source

Intersecting Molecular Pathways in Cardiovascular Disease and Diabetes Mellitus: Emerging Roles of Inflammation and Therapeutics

Diabetes/Metabolism Research and Reviews, Volume 42, Issue 4, May 2026.
Central illustration: Pathophysiological mechanisms linking diabetes mellitus and cardiovascular disease. Chronic hyperglycaemia, insulin resistance, and low‐grade inflammation contribute to endothelial dysfunction, myocardial fibrosis, and cardiomyocyte apoptosis.
Lilian Anagnostopoulou, Nikolaos Ktenopoulos, Anastasios Apostolos, Christos Fragoulis, Panayotis Vlachakis, Paschalis Karakasis, Marios Sagris, Nikias Milaras, Maria Drakopoulou, Andreas Synetos, Ioannis Kyriazis, Ioannis Ioannidis, Costas Tsioufis, Konstantinos Toutouzas   +13 more
wiley   +1 more source

Cholesterol Efflux Capacity and Its Association with Oxidative Stress in Myocardial Infarction. [PDF]

J Atheroscler Thromb
Endo Y, Sasaki K, Ikewaki K.
europepmc   +1 more source

Cholesterol Efflux Capacity and Its Association With Adverse Cardiovascular Events: A Systematic Review and Meta-Analysis. [PDF]

Front Cardiovasc Med, 2021
Lee JJ, Chi G, Fitzgerald C, Kazmi SHA, Kalayci A, Korjian S, Duffy D, Shaunik A, Kingwell B, Yeh RW, Bhatt DL, Gibson CM.   +11 more
europepmc   +1 more source

Gut Dysbiosis as a Shared Mechanism in Obesity and Hypertension: Exploring a Promising Therapeutic Avenue

Endocrinology, Diabetes &Metabolism, Volume 9, Issue 3, May 2026.
This review synthesises current knowledge on gut microbiome involvement in obesity and hypertension, evaluates microbiome‐based therapeutic strategies, and identifies critical research gaps to guide future investigations aimed at mitigating the dual pandemics.
Andrej Belančić, Almir Fajkić, Yusuf Ziya Sener, Ana Jelaković, Lejla Alić, Elvira Meni Maria Gkrinia, Donatella Verbanac, Bojan Jelaković   +7 more
wiley   +1 more source

Impact of metabolic-associated fatty liver disease on the cholesterol efflux capacity of high-density lipoproteins in adolescents with type 2 diabetes. [PDF]

Front Pediatr
Orozco Morales JA, Medina Urrutia AX, Tamayo MT, Reyes Barrera J, Galarza EJ, Juárez Rojas JG, Dies Suarez P, Méndez Sánchez N, Díaz Orozco LE, Velázquez-López L, Medina Bravo P.   +10 more
europepmc   +1 more source

Effect of CSL112 (apolipoprotein A-I [human]) on cholesterol efflux capacity in Japanese subjects: Findings from a phase I study and a cross-study comparison. [PDF]

Clin Transl Sci, 2022
Zheng B, Goto S, Clementi R, Feaster J, Duffy D, Dalitz P, Airey J, Korjian S, Tortorici MA, Roberts J, Gibson CM.   +10 more
europepmc   +1 more source

Fat Oxidation, But Not Subcutaneous Adipose Tissue Lipolysis, Differs Between Males and Females During a Treadmill‐Based Heat Tolerance Test

European Journal of Sport Science, Volume 26, Issue 5, May 2026.
ABSTRACT This study aimed to determine whether fat metabolism differs between males and females when exposed to extreme exercise‐heat stress. Physically active males (n = 11, 23 ± 4 years, 81.7 ± 11.8 kg, body fat 16.4 ± 6.6%) and females (n = 13, 25 ± 4 years, 60.4 ± 7.1 kg, 24.4 ± 6.7%) completed a 2‐h exercise‐heat tolerance test (40° $\boldsymbol{{}
Margaret C. Morrissey‐Basler, Michael R. Szymanski, Erica M. Filep, Sean P. Langan, Michael J. Ormsbee, Elaine C. Lee, Douglas J. Casa   +6 more
wiley   +1 more source